Please Wait a Moment
X
 

IMPORTANT ARTICLES

Archive by category: UncategorizedReturn
The aducanumab controversy is the latest example of surrogate endpoints failing to predict clinically important outcomes. Yet, as Jeanne Lenzer and Shannon Brownlee report, they increasingly provide the basis for drug approvals
Article
Archive by category: UncategorizedReturn
Not any article